vs

Side-by-side financial comparison of APTARGROUP, INC. (ATR) and Chime Financial, Inc. (CHYM). Click either name above to swap in a different company.

APTARGROUP, INC. is the larger business by last-quarter revenue ($982.9M vs $543.5M, roughly 1.8× Chime Financial, Inc.). APTARGROUP, INC. runs the higher net margin — 7.4% vs -10.1%, a 17.5% gap on every dollar of revenue. On growth, Chime Financial, Inc. posted the faster year-over-year revenue change (28.8% vs 10.8%). APTARGROUP, INC. produced more free cash flow last quarter ($53.3M vs $15.4M).

AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.

Chime Financial, Inc. is an American financial technology company based in San Francisco, California. It provides fee-free mobile banking services through two national banks, Stride Bank and The Bancorp Bank.

ATR vs CHYM — Head-to-Head

Bigger by revenue
ATR
ATR
1.8× larger
ATR
$982.9M
$543.5M
CHYM
Growing faster (revenue YoY)
CHYM
CHYM
+18.1% gap
CHYM
28.8%
10.8%
ATR
Higher net margin
ATR
ATR
17.5% more per $
ATR
7.4%
-10.1%
CHYM
More free cash flow
ATR
ATR
$37.9M more FCF
ATR
$53.3M
$15.4M
CHYM

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
ATR
ATR
CHYM
CHYM
Revenue
$982.9M
$543.5M
Net Profit
$72.8M
$-54.7M
Gross Margin
87.2%
Operating Margin
10.9%
-11.9%
Net Margin
7.4%
-10.1%
Revenue YoY
10.8%
28.8%
Net Profit YoY
-7.5%
-148.4%
EPS (diluted)
$1.12
$-0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATR
ATR
CHYM
CHYM
Q1 26
$982.9M
Q4 25
$962.7M
Q3 25
$961.1M
$543.5M
Q2 25
$966.0M
$528.1M
Q1 25
$887.3M
Q4 24
$848.1M
Q3 24
$909.3M
$421.9M
Q2 24
$910.1M
$384.2M
Net Profit
ATR
ATR
CHYM
CHYM
Q1 26
$72.8M
Q4 25
$74.3M
Q3 25
$127.9M
$-54.7M
Q2 25
$111.7M
$-923.4M
Q1 25
$78.8M
Q4 24
$100.9M
Q3 24
$100.0M
$-22.0M
Q2 24
$90.5M
$385.0K
Gross Margin
ATR
ATR
CHYM
CHYM
Q1 26
Q4 25
Q3 25
87.2%
Q2 25
87.3%
Q1 25
Q4 24
Q3 24
87.3%
Q2 24
86.9%
Operating Margin
ATR
ATR
CHYM
CHYM
Q1 26
10.9%
Q4 25
11.0%
Q3 25
14.2%
-11.9%
Q2 25
14.9%
-176.2%
Q1 25
12.8%
Q4 24
14.2%
Q3 24
15.2%
-7.3%
Q2 24
13.8%
-2.5%
Net Margin
ATR
ATR
CHYM
CHYM
Q1 26
7.4%
Q4 25
7.7%
Q3 25
13.3%
-10.1%
Q2 25
11.6%
-174.8%
Q1 25
8.9%
Q4 24
11.9%
Q3 24
11.0%
-5.2%
Q2 24
9.9%
0.1%
EPS (diluted)
ATR
ATR
CHYM
CHYM
Q1 26
$1.12
Q4 25
$1.13
Q3 25
$1.92
$-0.15
Q2 25
$1.67
$-7.29
Q1 25
$1.17
Q4 24
$1.48
Q3 24
$1.48
$-0.34
Q2 24
$1.34
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATR
ATR
CHYM
CHYM
Cash + ST InvestmentsLiquidity on hand
$229.5M
$445.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.6B
$1.4B
Total Assets
$5.1B
$2.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATR
ATR
CHYM
CHYM
Q1 26
$229.5M
Q4 25
$409.5M
Q3 25
$264.8M
$445.0M
Q2 25
$169.8M
$868.3M
Q1 25
$136.8M
Q4 24
$226.2M
Q3 24
$327.9M
$270.8M
Q2 24
$223.9M
$295.4M
Total Debt
ATR
ATR
CHYM
CHYM
Q1 26
Q4 25
$1.1B
Q3 25
$546.0M
Q2 25
$535.1M
Q1 25
$561.2M
Q4 24
$688.1M
Q3 24
$822.7M
Q2 24
$681.5M
Stockholders' Equity
ATR
ATR
CHYM
CHYM
Q1 26
$2.6B
Q4 25
$2.7B
Q3 25
$2.8B
$1.4B
Q2 25
$2.7B
$1.4B
Q1 25
$2.5B
Q4 24
$2.5B
Q3 24
$2.5B
$-1.9B
Q2 24
$2.4B
$-1.9B
Total Assets
ATR
ATR
CHYM
CHYM
Q1 26
$5.1B
Q4 25
$5.3B
Q3 25
$5.1B
$2.0B
Q2 25
$4.9B
$1.9B
Q1 25
$4.5B
Q4 24
$4.4B
Q3 24
$4.6B
Q2 24
$4.5B
Debt / Equity
ATR
ATR
CHYM
CHYM
Q1 26
Q4 25
0.43×
Q3 25
0.20×
Q2 25
0.20×
Q1 25
0.22×
Q4 24
0.28×
Q3 24
0.32×
Q2 24
0.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATR
ATR
CHYM
CHYM
Operating Cash FlowLast quarter
$17.5M
Free Cash FlowOCF − Capex
$53.3M
$15.4M
FCF MarginFCF / Revenue
5.4%
2.8%
Capex IntensityCapex / Revenue
6.7%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$327.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATR
ATR
CHYM
CHYM
Q1 26
Q4 25
$183.7M
Q3 25
$177.6M
$17.5M
Q2 25
$126.0M
$2.7M
Q1 25
$82.7M
Q4 24
$178.2M
Q3 24
$229.3M
Q2 24
$143.6M
Free Cash Flow
ATR
ATR
CHYM
CHYM
Q1 26
$53.3M
Q4 25
$96.9M
Q3 25
$114.3M
$15.4M
Q2 25
$62.5M
$-888.0K
Q1 25
$25.9M
Q4 24
$112.2M
Q3 24
$162.7M
Q2 24
$75.4M
FCF Margin
ATR
ATR
CHYM
CHYM
Q1 26
5.4%
Q4 25
10.1%
Q3 25
11.9%
2.8%
Q2 25
6.5%
-0.2%
Q1 25
2.9%
Q4 24
13.2%
Q3 24
17.9%
Q2 24
8.3%
Capex Intensity
ATR
ATR
CHYM
CHYM
Q1 26
6.7%
Q4 25
9.0%
Q3 25
6.6%
0.4%
Q2 25
6.6%
0.7%
Q1 25
6.4%
Q4 24
7.8%
Q3 24
7.3%
Q2 24
7.5%
Cash Conversion
ATR
ATR
CHYM
CHYM
Q1 26
Q4 25
2.47×
Q3 25
1.39×
Q2 25
1.13×
Q1 25
1.05×
Q4 24
1.77×
Q3 24
2.29×
Q2 24
1.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATR
ATR

Segment breakdown not available.

CHYM
CHYM

Payments Revenue$363.2M67%
Platform Related Revenue$180.4M33%

Related Comparisons